Frequency, pathologic characterization, and impact of DHL/THL
Readers are encouraged to review the original references for the details. Only most informative studies related to data in this table are included. Other studies are included in the text.
*Some studies may include the same or overlapping patient populations.
†N/A, Not applicable/available because of entry criteria for study (ie, included only cases with MYC-R or only DHL/THL) or no data.
‡Therapy-related issues discussed in detail in the chapter by Dunleavy.